|
|
Volumn 22, Issue 12, 2013, Pages 1286-1294
|
|
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BELIMUMAB;
CYCLOPHOSPHAMIDE;
GLUCOCORTICOID;
HYDROXYCHLOROQUINE;
IMMUNOSUPPRESSIVE AGENT;
PREDNISONE;
RITUXIMAB;
VACCINE;
BACTERIAL INFECTION;
CELLULAR IMMUNITY;
HUMAN;
HUMORAL IMMUNITY;
IMMUNOCOMPROMISED PATIENT;
INFECTIONS;
MORTALITY;
MYCOSIS;
OPPORTUNISTIC INFECTION;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
SYSTEMIC LUPUS ERYTHEMATOSUS;
VACCINATION;
VIRUS INFECTION;
BELIMUMAB;
CYCLOPHOSPHAMIDE;
GLUCOCORTICOIDS;
HYDROXYCHLOROQUINE;
INFECTIONS;
PREDNISONE;
RITUXIMAB;
VACCINATION;
BACTERIAL INFECTIONS;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNITY, HUMORAL;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MYCOSES;
OPPORTUNISTIC INFECTIONS;
RISK FACTORS;
VACCINES;
VIRUS DISEASES;
|
|
EID: 84901505254
PISSN: None
EISSN: 14770962
Source Type: Journal
DOI: 10.1177/0961203313493032 Document Type: Review |
|
Times cited : (289)
|
|
References (0)
|
